These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26537222)

  • 1. Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014/15.
    Pebody RG; Green HK; Andrews N; Boddington NL; Zhao H; Yonova I; Ellis J; Steinberger S; Donati M; Elliot AJ; Hughes HE; Pathirannehelage S; Mullett D; Smith GE; de Lusignan S; Zambon M
    Euro Surveill; 2015; 20(39):. PubMed ID: 26537222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake and impact of a new live attenuated influenza vaccine programme in England: early results of a pilot in primary school-age children, 2013/14 influenza season.
    Pebody RG; Green HK; Andrews N; Zhao H; Boddington N; Bawa Z; Durnall H; Singh N; Sunderland A; Letley L; Ellis J; Elliot AJ; Donati M; Smith GE; de Lusignan S; Zambon M
    Euro Surveill; 2014 Jun; 19(22):. PubMed ID: 24925457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake and impact of vaccinating primary school-age children against influenza: experiences of a live attenuated influenza vaccine programme, England, 2015/16.
    Pebody RG; Sinnathamby MA; Warburton F; Andrews N; Boddington NL; Zhao H; Yonova I; Ellis J; Tessier E; Donati M; Elliot AJ; Hughes HE; Pathirannehelage S; Byford R; Smith GE; de Lusignan S; Zambon M
    Euro Surveill; 2018 Jun; 23(25):. PubMed ID: 29945698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake and impact of vaccinating primary school children against influenza: Experiences in the fourth season of the live attenuated influenza vaccination programme, England, 2016/2017.
    Sinnathamby MA; Warburton F; Andrews N; Boddington NL; Zhao H; Ellis J; Tessier E; Donati M; Elliot AJ; Hughes HE; Byford R; Smith GE; Tripathy M; de Lusignan S; Zambon M; Pebody RG
    Influenza Other Respir Viruses; 2022 Jan; 16(1):113-124. PubMed ID: 34405555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination.
    Levine MZ; Martin JM; Gross FL; Jefferson S; Cole KS; Archibald CA; Nowalk MP; Susick M; Moehling K; Spencer S; Chung JR; Flannery B; Zimmerman RK
    Clin Vaccine Immunol; 2016 Oct; 23(10):831-839. PubMed ID: 27558294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children during the 2014-2015 season.
    McLean HQ; Caspard H; Griffin MR; Poehling KA; Gaglani M; Belongia EA; Talbot HK; Peters TR; Murthy K; Ambrose CS
    Vaccine; 2017 May; 35(20):2685-2693. PubMed ID: 28408121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results.
    Pebody R; Warburton F; Andrews N; Ellis J; von Wissmann B; Robertson C; Yonova I; Cottrell S; Gallagher N; Green H; Thompson C; Galiano M; Marques D; Gunson R; Reynolds A; Moore C; Mullett D; Pathirannehelage S; Donati M; Johnston J; de Lusignan S; McMenamin J; Zambon M
    Euro Surveill; 2015; 20(36):. PubMed ID: 26535911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season.
    Pebody R; Sile B; Warburton F; Sinnathamby M; Tsang C; Zhao H; Ellis J; Andrews N
    Euro Surveill; 2017 Jan; 22(4):. PubMed ID: 28182539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17.
    Pebody R; Warburton F; Ellis J; Andrews N; Potts A; Cottrell S; Reynolds A; Gunson R; Thompson C; Galiano M; Robertson C; Gallagher N; Sinnathamby M; Yonova I; Correa A; Moore C; Sartaj M; de Lusignan S; McMenamin J; Zambon M
    Euro Surveill; 2017 Nov; 22(44):. PubMed ID: 29113630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the childhood influenza vaccine programme on antibiotic prescribing rates in primary care in England.
    Muller-Pebody B; Sinnathamby MA; Warburton F; Rooney G; Andrews N; Whitaker H; Henderson KL; Tsang C; Hopkins S; Pebody RG
    Vaccine; 2021 Oct; 39(45):6622-6627. PubMed ID: 34627625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study.
    Buchan SA; Booth S; Scott AN; Simmonds KA; Svenson LW; Drews SJ; Russell ML; Crowcroft NS; Loeb M; Warshawsky BF; Kwong JC
    JAMA Pediatr; 2018 Sep; 172(9):e181514. PubMed ID: 29971427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial.
    Kwong JC; Pereira JA; Quach S; Pellizzari R; Dusome E; Russell ML; Hamid JS; Feinberg Y; Winter AL; Gubbay JB; Sirtonski B; Moher D; Sider D; Finkelstein M; Loeb M;
    Vaccine; 2015 Jan; 33(4):535-41. PubMed ID: 25488331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phased introduction of a universal childhood influenza vaccination programme in England: population-level factors predicting variation in national uptake during the first year, 2013/14.
    Green HK; Andrews N; Letley L; Sunderland A; White J; Pebody R
    Vaccine; 2015 May; 33(22):2620-8. PubMed ID: 25835576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of influenza vaccine in children in preventing influenza associated hospitalisation, 2018/19, England.
    Pebody RG; Zhao H; Whitaker HJ; Ellis J; Donati M; Zambon M; Andrews N
    Vaccine; 2020 Jan; 38(2):158-164. PubMed ID: 31648914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.
    Simpson CR; Lone NI; Kavanagh K; Englishby T; Robertson C; McMenamin J; Wissman BV; Vasileiou E; Butler CC; Ritchie LD; Gunson R; Schwarze J; Sheikh A
    Health Technol Assess; 2020 Dec; 24(67):1-66. PubMed ID: 33256892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013-2014 Through 2015-2016.
    McLean HQ; King JP; Talley P; Flannery B; Spencer S; Levine MZ; Friedrich TC; Belongia EA
    J Pediatric Infect Dis Soc; 2020 Apr; 9(2):173-180. PubMed ID: 30759228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results.
    Pebody R; Warburton F; Ellis J; Andrews N; Potts A; Cottrell S; Johnston J; Reynolds A; Gunson R; Thompson C; Galiano M; Robertson C; Byford R; Gallagher N; Sinnathamby M; Yonova I; Pathirannehelage S; Donati M; Moore C; de Lusignan S; McMenamin J; Zambon M
    Euro Surveill; 2016 Sep; 21(38):. PubMed ID: 27684603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.